Drug-eluting stents beat bare-metal stents when used off-label, says study
This article was originally published in Clinica
Executive Summary
A study of the off-label use of drug-eluting stents (DESs) shows that the devices do not carry an increased risk of death compared to bare-metal stents (BMSs).